These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 1488568

  • 1. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH, Luursema PB, Sips AP, Beumer HM, Wald FD, Cornelissen PJ.
    Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP, Greefhorst LP, Smeets JJ, Wald FD, Cornelissen PJ.
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [Abstract] [Full Text] [Related]

  • 3. Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler.
    Goldberg J, Freund E, Beckers B, Hinzmann R.
    Eur Respir J; 2001 Feb; 17(2):225-32. PubMed ID: 11334124
    [Abstract] [Full Text] [Related]

  • 4. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [Abstract] [Full Text] [Related]

  • 5. Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPD.
    Kilfeather SA, Ponitz HH, Beck E, Schmidt P, Lee A, Bowen I, Hesse Ch.
    Respir Med; 2004 May; 98(5):387-97. PubMed ID: 15139567
    [Abstract] [Full Text] [Related]

  • 6. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
    Kunkel G, Magnussen H, Bergmann K, Juergens UR, de Mey C, Freund E, Hinzmann R, Beckers B.
    Respiration; 2000 May; 67(3):306-14. PubMed ID: 10867600
    [Abstract] [Full Text] [Related]

  • 7. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A, Muir JF, Benhamou D, Weitzenblum E, Zuck P, Delacenserie R, Taytard A, Iacono P.
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [Abstract] [Full Text] [Related]

  • 8. Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution.
    Marlin GE.
    Respiration; 1986 Feb; 50 Suppl 2():290-3. PubMed ID: 2951824
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
    Huchon G, Hofbauer P, Cannizzaro G, Iacono P, Wald F.
    Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
    [Abstract] [Full Text] [Related]

  • 10. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
    Guerin C, Chevre A, Dessirier P, Poncet T, Becquemin MH, Dequin PF, Le Guellec C, Jacques D, Fournier G.
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
    [Abstract] [Full Text] [Related]

  • 11. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Tsukino M, Mishima M, Izumi T.
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [Abstract] [Full Text] [Related]

  • 12. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM, Phillips C, Wooler PA.
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A, Jeena PM, Soemantri PA, Vertruyen A, Schmidt P, Gerken F, Razzouk H.
    Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
    [Abstract] [Full Text] [Related]

  • 14. Improved delivery of ipratropium bromide using Respimat (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD.
    Iacono P, Velicitat P, Guemas E, Leclerc V, Thébault JJ.
    Respir Med; 2000 May; 94(5):490-5. PubMed ID: 10868713
    [Abstract] [Full Text] [Related]

  • 15. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF.
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [Abstract] [Full Text] [Related]

  • 16. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
    Packe GE, Archer PS, Cayton RM.
    Postgrad Med J; 1984 May; 60 Suppl 1():18-22. PubMed ID: 6233546
    [Abstract] [Full Text] [Related]

  • 17. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P, Hederer B, Austen G, Dewberry H, Meyer T.
    Int J Chron Obstruct Pulmon Dis; 2008 May; 3(4):763-70. PubMed ID: 19281091
    [Abstract] [Full Text] [Related]

  • 18. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 19. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F, Hodder R, Bateman ED.
    Drugs; 2004 Sep; 64(15):1671-82. PubMed ID: 15257628
    [Abstract] [Full Text] [Related]

  • 20. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E, Elsasser S, Karrer W, Grossenbacher M, Emmons R, Perruchoud AP.
    Respiration; 1993 Sep; 60(2):84-8. PubMed ID: 8341859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.